文献速递乳腺癌

乳腺癌患者亲属的风险适应性筛查起始年龄

Risk-Adapted Starting Age of Screening for Relatives of Patients With Breast Cancer.
PubMed 文献 · JAMA Oncol · 2020-01-01

结果显示筛查起始年龄随患病一级/二级亲属数量及最年轻亲属诊断年龄而变化,如有多个患病一级亲属且最年轻者50岁前诊断,风险达标年龄为27岁,若最年轻者50岁后诊断则为36岁。

要点

  • 有多个患病一级亲属且最年轻者50岁前诊断,风险达标年龄为27岁
  • 最年轻患病亲属50岁后诊断时,风险达标年龄为36岁
  • 筛查起始年龄应结合一级和二级亲属的患病数量及诊断年龄个体化确定

核心结论

  • 基于人群登记数据可识别乳腺癌筛查的风险适应性起始年龄,为现有筛查指南补充高质量证据。

主要发现

  • 筛查风险适应性起始年龄随患病一级和二级亲属数量及一级亲属诊断年龄而变化。

关键数值与推荐

  • 以一般人群50岁筛查推荐对应的10年累积风险2.2%为基准风险水平。
  • 有多个患病一级亲属且最年轻患病亲属50岁前诊断时,达到基准风险水平的年龄为27岁。
  • 最年轻患病亲属50岁后诊断时,达到基准风险水平的年龄为36岁。

临床怎么用

  • 对有乳腺癌家族史的女性,可根据患病一级和二级亲属数量及最年轻亲属诊断年龄,参考相应风险达标年龄考虑提前启动筛查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Breast cancer screening guidelines acknowledge the need for earlier screening for women at increased risk but provide limited guidance for women with a family history of breast cancer. A risk-adapted starting age of screening for relatives of patients with breast cancer may help supplement current screening guidelines. OBJECTIVE: To identify the risk-adapted starting age of breast cancer screening on the basis of a woman's detailed family history. DESIGN, SETTING, AND PARTICIPANTS: This nationwide cohort study analyzed data recorded in the Swedish family-cancer data sets. All women born from 1932 onward and with at least 1 known first-degree relative (FDR) were included (N = 5 099 172). Data from January 1, 1958, to December 31, 2015, were collected. Data were analyzed from October 1, 2017, to March 31, 2019. EXPOSURES: Family history of breast cancer in FDRs and second-degree relatives (SDRs). MAIN OUTCOMES AND MEASURES: Primary invasive breast cancer diagnosis and the age at which women with different constellations of family history attained the risk level at which breast screening is usually recommended. RESULTS: Of the 5 099 172 women included in the study, 118 953 (2.3%) received a diagnosis of primary invasive breast cancer. A total of 102 751 women (86.4%; mean [SD] age at diagnosis, 55.9 [11.1] years) did not have family history of breast cancer in FDRs and SDRs at the time of their diagnosis. Risk-adapted starting age of breast cancer screening varied by number of FDRs and SDRs with breast cancer diagnosis and the age at diagnosis of the FDRs. For example, for screening recommendation at age 50 years for the general population (2.2% 10-year cumulative risk), women with multiple affected FDRs, with the youngest affected relative receiving a diagnosis before age 50 years, reached the benchmark risk level at age 27 years. When the youngest relative received a diagnosis after age 50 years, however, this risk level was attained at age 36 years. CONCLUSIONS AND RELEVANCE: This study identifies possible risk-based starting ages for breast cancer screening based on population-based registers. These results may serve as high-quality evidence to supplement current screening guidelines for relatives of patients with breast cancer.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Mukama T, Kharazmi E, Xu X, et al. Risk-Adapted Starting Age of Screening for Relatives of Patients With Breast Cancer. JAMA Oncol. 2020. PMID: 31725845. doi:10.1001/jamaoncol.2019.3876

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。